IN2012DN02837A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02837A
IN2012DN02837A IN2837DEN2012A IN2012DN02837A IN 2012DN02837 A IN2012DN02837 A IN 2012DN02837A IN 2837DEN2012 A IN2837DEN2012 A IN 2837DEN2012A IN 2012DN02837 A IN2012DN02837 A IN 2012DN02837A
Authority
IN
India
Prior art keywords
sequence
mutant
cyanovirin
derivative
pharmaceutical preparations
Prior art date
Application number
Other languages
English (en)
Inventor
Sheng Xiong
Wei Chen
Chuiwen Qian
Yifei Wang
Kaio Kitazato
Original Assignee
Univ Jinan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Jinan filed Critical Univ Jinan
Publication of IN2012DN02837A publication Critical patent/IN2012DN02837A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
IN2837DEN2012 2009-09-04 2010-05-24 IN2012DN02837A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2009101920630A CN101638435B (zh) 2009-09-04 2009-09-04 一种蓝藻病毒蛋白n突变体、其修饰衍生物及应用
PCT/CN2010/073124 WO2011026351A1 (zh) 2009-09-04 2010-05-24 一种蓝藻病毒蛋白n 突变体、其修饰衍生物及应用

Publications (1)

Publication Number Publication Date
IN2012DN02837A true IN2012DN02837A (enExample) 2015-07-24

Family

ID=41613629

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2837DEN2012 IN2012DN02837A (enExample) 2009-09-04 2010-05-24

Country Status (4)

Country Link
JP (1) JP5592490B2 (enExample)
CN (1) CN101638435B (enExample)
IN (1) IN2012DN02837A (enExample)
WO (1) WO2011026351A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101638435B (zh) * 2009-09-04 2011-11-16 暨南大学 一种蓝藻病毒蛋白n突变体、其修饰衍生物及应用
EP2955192B1 (en) * 2013-02-05 2020-07-01 Agricultural Technology Research Institute Anti-mycoplasma spp. subunit vaccine
CN110903363A (zh) * 2019-11-26 2020-03-24 中国药科大学 一种蓝藻抗病毒蛋白n的制备方法及应用
CN111494604B (zh) * 2020-05-11 2022-05-06 中国药科大学 蓝藻抗病毒蛋白n在制备抗炎药物中的应用
US20230355708A1 (en) * 2020-09-29 2023-11-09 Drexel University Compositions for inhibiting viral entry and methods using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843882A (en) * 1995-04-27 1998-12-01 The United States Of America As Represented By The Department Of Health And Human Services Antiviral proteins and peptides
WO2003080115A1 (fr) * 2002-03-22 2003-10-02 Bipha Corporation Complexes peptide hydrophile - immunoglobuline
WO2004056852A2 (en) * 2002-12-19 2004-07-08 Nektar Therapeutics Al, Corp. Cyanovirin variant-polymer conjugates
CN101705241B (zh) * 2008-09-28 2012-06-06 暨南大学 重组蓝藻抗病毒蛋白的制备方法及应用
CN101638435B (zh) * 2009-09-04 2011-11-16 暨南大学 一种蓝藻病毒蛋白n突变体、其修饰衍生物及应用

Also Published As

Publication number Publication date
CN101638435A (zh) 2010-02-03
WO2011026351A1 (zh) 2011-03-10
CN101638435B (zh) 2011-11-16
JP2013503609A (ja) 2013-02-04
JP5592490B2 (ja) 2014-09-17

Similar Documents

Publication Publication Date Title
NZ707439A (en) Modified factor ix polypeptides and uses thereof
EP4014982A3 (en) Composition for inducing proliferation or accumulation of regulatory t cells
AR110834A2 (es) MOLÉCULA DE UNA VARIANTE AISLADA DE FENILALANINA AMONIACOLIASA DE ANABAENA VARIABILIS (AvPal)
NZ704191A (en) Cell-penetrating peptides and uses therof
NZ600690A (en) Fkbp-l and uses thereof
NZ600731A (en) Oxyntomodulin peptide analogue
IN2012DN02837A (enExample)
NZ600732A (en) Oxyntomodulin peptide analogue
NZ602504A (en) Antiviral vaccines with improved cellular immunogenicity
ES2571757T3 (es) Microorganismos con rango de utilización de sustrato ampliado
NZ599598A (en) Hyperblebbing shigella strains
EA201170879A1 (ru) Полипептиды с ксиланазной активностью
NZ603200A (en) Peptides and their use
IN2012DN00801A (enExample)
NZ586430A (en) Mutant forms of streptolysin o (slo)
NZ601488A (en) Immunogenic proteins and compositions
UA100127C2 (ru) Пептид cdh3 и лекарственное средство, содержащее его
MY169650A (en) Crystalline recombinant interferon with altered spatial configuration,three-dimensional structure and uses thereof
BR112014002173A2 (pt) proteínas purificadas
WO2012124998A3 (ko) 바이오핀
WO2011107948A3 (en) Ligands of insulin degrading enzyme and their uses
SI2089433T1 (sl) Terapevtsko ciljan katepsin s
WO2006056487A3 (en) Peptides useful as dual caspase-2/-6 inhibitors and their biological applications
BR112014001844A2 (pt) gene induzindo o alongamento de raízes ou aumentando a biomassa, e uso do mesmo
WO2008148932A3 (en) Glycosylasparaginase for treatment of cancers or inflammatory diseases